Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Stress might contribute to hair loss in alopecia areata.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Trichohyalin may trigger the immune response causing alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PRP more effective than minoxidil 5% for treating alopecia areata.

New genetic discoveries may lead to better treatments for alopecia areata.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Both mouse and rat models are effective for testing alopecia areata treatments.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

Alopecia areata patients often have eczema, thyroid issues, vitamin-D deficiency, and anemia.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Coudability hairs are useful markers for alopecia areata activity.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.